Since 2013, thought leaders, innovators, and health care specialists have convened for a one day summit to discuss the business of personalized medicine. The Business of Personalized Medicine Summit, explores the economic, legal and regulatory barriers to making personalized medicine a reality for patients everywhere while sharing strategies for success. This year’s Summit – Strategies for Partnering and Collaboration – explores new partnering models across and within the health care and pharmaceutical industries that facilitate the research, development and adoption of personalized or precision medicine.
Ms. Margaret Anderson Executive Director of FasterCures, will open the 2016 Summit. Ms. Anderson will share how FasterCures is accelerating medical progress by spurring cross-sector collaboration and cultivating a culture of innovation. FasterCures is a Washington DC-based center of the Milken Institute, which is driven by a singular goal – to save lives by speeding up and improving the medical research system. Through its various programs and initiatives, the center connects hundreds of decision-makers from across diseases who have the experience, creativity, and motivation needed to get new therapies from discovery to patients faster and more affordably.
Other confirmed speakers include, Jonathan Hirsch, President and Founder, Syapse; Anita Chawla, PhD., Managing Principal, Analysis Group; Kalidip “KC” Choudhury, PhD, Vice President, Business Development, XBiotech; Nichoas Donoghoe, MD Partner, McKinsey & Co.; John Doulis, MD, Chief Informatics and Information Officer, Medcare Investment Funds; Leeland Ekstrom, PhD, Managing Director, BioVu Partnership, Vanderbilt University Medical Center; Matt Gardner, Founder & Chief Executive Officer, California Technology Council; Jeff Karan, Managing Partner, Mavericks Capital; Jennifer Levin Carter, MD, PhD, Chief Medical Officer & Founder, N-of-One; Sally A. Howard , JD, Head of Regulatory Affairs and Policy, Human Longevity, Inc.; Maurie A. Markman, MD, President of Medicine and Science, Cancer Treatment Centers of America; Samuel D. Ricitelli, President, Chief Executive Officer & Director, Signal Genetics, Inc.; Ashley Van Zeeland, PhD., MBA, Chief Technology Officer, Human Longevity, Inc.; and Chris Meda, Chief Business Officer, InCellDx.
Please join us and co-host The Personalized Medicine Coalition on September 29th, 2016 at the South San Francisco Conference Center to meet our speakers and network with industry leaders. Registration and additional information on the Summit can be found here.